Answers are grounded in this paper and cite their sources.
Multicenter, retrospective study finds cost savings by optimizing tests in orbital inflammation management, suggesting risk-based approaches.
Orbital inflammation was associated with a broad diagnostic work-up that led to a nonspecific diagnosis in the majority of cases. Cost savings may be achieved by judicious use of tests that provide limited diagnostic information (ANA, anti-dsDNA, ACE, anti-CCP, ESR, CRP, platelets) and reserving comprehensive work-up for patients with risk factors.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: